Regulatory Post Marketing Surveillance of Intelence Tablet
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2015
At a glance
- Drugs Etravirine (Primary)
- Indications Acquired immunodeficiency syndrome
- Focus Adverse reactions
- Sponsors Janssen
- 31 Aug 2018 Biomarkers information updated
- 29 Sep 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 11 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.